| Title |
Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials
|
|---|---|
| Published in |
Annals of Surgical Oncology, March 2013
|
| DOI | 10.1245/s10434-013-2887-8 |
| Pubmed ID | |
| Authors |
Anne M. Wallace, Linda K. Han, Stephen P. Povoski, Kenneth Deck, Schlomo Schneebaum, Nathan C. Hall, Carl K. Hoh, Karl K. Limmer, Helen Krontiras, Thomas G. Frazier, Charles Cox, Eli Avisar, Mark Faries, Dennis W. King, Lori Christman, David R. Vera |
| Abstract |
Sentinel lymph node (SLN) surgery is used worldwide for staging breast cancer patients and helps limit axillary lymph node dissection. [(99m)Tc]Tilmanocept is a novel receptor-targeted radiopharmaceutical evaluated in 2 open-label, nonrandomized, within-patient, phase 3 trials designed to assess the lymphatic mapping performance. |
Mendeley readers
The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 2% |
| Unknown | 63 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 12 | 19% |
| Student > Bachelor | 10 | 16% |
| Other | 9 | 14% |
| Researcher | 6 | 9% |
| Student > Master | 6 | 9% |
| Other | 12 | 19% |
| Unknown | 9 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 27 | 42% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 8% |
| Chemistry | 5 | 8% |
| Nursing and Health Professions | 4 | 6% |
| Agricultural and Biological Sciences | 2 | 3% |
| Other | 10 | 16% |
| Unknown | 11 | 17% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2013.
All research outputs
#1,989,126
of 22,703,044 outputs
Outputs from Annals of Surgical Oncology
#447
of 6,428 outputs
Outputs of similar age
#18,809
of 216,179 outputs
Outputs of similar age from Annals of Surgical Oncology
#1
of 37 outputs
Altmetric has tracked 22,703,044 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,428 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 216,179 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.